COMMUNIQUÉS West-GlobeNewswire

VitalHub Holds First MCAP User Group Conference at Canada House in UK
11/06/2019
TORONTO, June 11, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce it will be holding its first MCAP user conference in the United Kingdom on June 13, 2019. The [...]
Blueberries and SLANG Worldwide Enter into Strategic Partnership for Colombia and Argentina
11/06/2019
TORONTO, June 11, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. ( CSE: BBM ) (OTCQB: BBRRF) (FRA: 1OA) (" Blueberries "), a leading Latin American licensed producer of medicinal cannabis and cannabis-derived [...]
Clearside Biomedical to Present at the JMP Securities Life Sciences Conference
11/06/2019
ALPHARETTA, Ga., June 11, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Helius Medical Technologies, Inc. Announces Scientific Publication Confirming Tongue Stimulation with PoNS™ Alters Brain Activity
11/06/2019
NEWTOWN, Pa., June 11, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported that a [...]
G1 Therapeutics to Present at Raymond James Life Sciences and MedTech Conference
11/06/2019
RESEARCH TRIANGLE PARK, N.C., June 11, 2019 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced that Chief Executive Officer Mark Velleca, M.D., Ph.D. will [...]
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Autism Spectrum Disorder with Cannabidiol
11/06/2019
DEVON, Pa., June 11, 2019 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]
Iovance Biotherapeutics Appoints Athena Countouriotis, M.D., to Board of Directors
11/06/2019
SAN CARLOS, Calif., June 11, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL [...]
CymaBay Therapeutics Reports Topline 12-Week Data from an Ongoing Phase 2b Study of Seladelpar in Patients with Nonalcoholic Steatohepatitis
11/06/2019
- Reductions in liver fat were minimal and not significant compared to placebo - Reductions in markers of liver injury were robust and clinically meaningful - Seladelpar appears to be safe and well-tolerated across all [...]
Parallax Health Sciences, Inc. Provides First Half 2019 Shareholder Update
11/06/2019
Company Completes Corporate Realignment Program to Focus on Generating Revenues from Point of Care Businesses and Intellectual Property Monetization SANTA MONICA, CA, June 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE [...]
LHC Group is top performer in latest CMS Star quality and patient satisfaction scores
11/06/2019
LAFAYETTE, La., June 11, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc.’s (NASDAQ: LHCG) most recent Centers for Medicare and Medicaid Services (CMS) Five-Star Quality Rating System results showed an increase in both quality [...]
Panag Pharma Completes Phase 3 Trial With Awaye™
11/06/2019
Recently acquired by Tetra Bio-Pharma, Panag Pharma’s terpene-derived topical product is aimed at pain caused by osteoarthritis of the knee OTTAWA, June 11, 2019 (GLOBE NEWSWIRE) -- Panag Pharma Inc., a subsidiary of [...]
Medcolcanna Strengthens Board of Directors with Addition of Pharmaceutical Executive
11/06/2019
BOGOTÁ, Colombia, June 11, 2019 (GLOBE NEWSWIRE) -- Medcolcanna Organics Inc . (TSX-V: MCCN) (“ Medcolcanna ” or the “ Company ”), a Canadian medical cannabis company with operations in Colombia, is pleased to announce [...]
Share buy-back week 23/2019
11/06/2019
Announcement 11 June 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
De nouveaux membres prennent place sur le conseil d’administration de la Fondation de l’Institut de Cardiologie de Montréal
11/06/2019
MONTRÉAL, 11 juin 2019 (GLOBE NEWSWIRE) -- La Fondation de l’Institut de Cardiologie de Montréal est heureuse d’annoncer l’arrivée de cinq administrateurs dans son conseil d’administration. Eve-Lyne Biron , [...]
Mesoblast and JCR Pharmaceuticals Expand Japan License Agreement to Use of Mesenchymal Stem Cells in Newborns With Insufficient Blood Flow to the Brain
11/06/2019
NEW YORK and MELBOURNE, Australia, June 11, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today announced it has expanded its partnership with JCR Pharmaceuticals Co. Ltd. in Japan to the use of [...]
Change in Orion Corporation's holding of treasury shares
11/06/2019
ORION CORPORATION STOCK EXCHANGE RELEASE 11 JUNE 2019 at 11.45 EEST Change in Orion Corporation's holding of treasury shares A total of 238 Orion class B shares have been returned free of consideration to Orion [...]
Philips spotlights AI-powered health information management solutions at HIMSS & Health 2.0 Europe
11/06/2019
June 11, 2019 Intelligent Connected Care solutions feature expansion of Philips IntelliSpace Enterprise Edition, Tasy EMR and Tele-ICU technology into Europe Amsterdam, the Netherlands and Helsinki, Finland – Royal [...]
Philips’ Future Health Index 2019 report focuses on the role digital health technology plays in improving both the clinician and patient experience
11/06/2019
June 11, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2019 report: ‘Transforming [...]
Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38
11/06/2019
Company Announcement Genmab signs agreement with Janssen Biotech, Inc. to collaborate exclusively on next-generation CD38 antibody product, HexaBody ® -CD38, incorporating Genmab’s proprietary HexaBody technology New [...]

Pages